| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/06/2008 | EP1953231A1 Compositions and methods for modifying gene expression using the promoter of ubiquitin conjugating protein coding gene of cotton plants |
| 08/06/2008 | EP1953230A1 Improved in vivo production of cephalosporins |
| 08/06/2008 | EP1953229A2 Metastatic breast and colon cancer regulated genes |
| 08/06/2008 | EP1953228A1 Method to diminish cd83 expression in monocyte-derived dendritic cells, t-cells and b-cells by RNAi |
| 08/06/2008 | EP1953227A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 08/06/2008 | EP1953226A1 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 08/06/2008 | EP1953225A1 Novel transporter protein in mammal and utilization of the same |
| 08/06/2008 | EP1953224A1 Method of modifying chromosome |
| 08/06/2008 | EP1953223A1 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products |
| 08/06/2008 | EP1953222A1 Improvement of cell growth |
| 08/06/2008 | EP1953221A2 Bilirubin oxidase mutant having thermal stability |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1952886A2 Thermal cycling system and method of use |
| 08/06/2008 | EP1952792A1 Methods of using FET labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 08/06/2008 | EP1952293A2 Methods for the identification of microrna and their applications in research and human health |
| 08/06/2008 | EP1951910A2 Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same |
| 08/06/2008 | EP1951902A1 Methods and compositions for the assessment of cardiovascular function and disorders |
| 08/06/2008 | EP1951887A2 Staphylococcus aureus strain cyl1892 |
| 08/06/2008 | EP1951883A2 Methods for quantifying polymer attachment to a particle |
| 08/06/2008 | EP1951882A2 Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences |
| 08/06/2008 | EP1951881A1 Methods and compositions for modulation of stem cell aging |
| 08/06/2008 | EP1951880A2 Polynucleotides encoding lignin biosynthetic pathway enzymes in coffee |
| 08/06/2008 | EP1951879A2 Plants having an increased content of amino sugars |
| 08/06/2008 | EP1951878A2 Plants with increased hyaluronan production |
| 08/06/2008 | EP1951877A1 Translational elongation factor promoter from pichia pastoris and method for producing recombinant protein using the same |
| 08/06/2008 | EP1951876A2 Chimeric antigens and vaccines |
| 08/06/2008 | EP1951875A2 Deregulated bacteria with improved polyhydroxyalkanoate production |
| 08/06/2008 | EP1951874A1 Minimal bacterial genome |
| 08/06/2008 | EP1951873A2 Rna interference mediated inhibition of influenza virus gene expression using short interfering nucleic acid |
| 08/06/2008 | EP1951872A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 08/06/2008 | EP1951871A1 Anti-hepatitis b virus ribozymal nucleic acid |
| 08/06/2008 | EP1951870A1 Dna constructs for specific inhibition of gene expression by rna interference |
| 08/06/2008 | EP1951866A1 Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 08/06/2008 | EP1951865A1 Stabilizing formulations for recombinant viruses |
| 08/06/2008 | EP1951760A2 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 08/06/2008 | EP1951752A1 Non-activated wnt inhibition polypeptides and method for preparing the same |
| 08/06/2008 | EP1951748A2 Hepatitis c virus variants |
| 08/06/2008 | EP1951736A1 Multitargeting interfering rnas and methods of their use and design |
| 08/06/2008 | EP1951320A2 Methods of analysing cell behaviour |
| 08/06/2008 | EP1951319A2 Chimeric immunoreceptor useful in treating human cancers |
| 08/06/2008 | EP1951318A1 Inhibition of autophagy genes in cancer chemotherapy |
| 08/06/2008 | EP1951297A2 Adenoviral vector-based foot-and-mouth disease vaccine |
| 08/06/2008 | EP1951263A1 Multitargeting interfering rnas having two active strands and methods for their design and use |
| 08/06/2008 | EP1951035A2 Transgenic rats and spermatogonial stem cells |
| 08/06/2008 | EP1951030A1 Improved methods and means for producings hyaluronan |
| 08/06/2008 | EP1899860A4 Method of processing and/or genome mapping of ditag sequences |
| 08/06/2008 | EP1740722B1 Method and assembly for dna isolation with dry reagents |
| 08/06/2008 | EP1659171B1 Novel microorganism and method of treating organic solid matters with the use of the microorganism |
| 08/06/2008 | EP1557465B1 Cap-binding protein |
| 08/06/2008 | EP1546335B1 Genetic manipulation of condensed tannins |
| 08/06/2008 | EP1516061B1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 08/06/2008 | EP1508047B1 Method for identifying immunoreactive peptides |
| 08/06/2008 | EP1498487B1 35 kd protein |
| 08/06/2008 | EP1478777B1 Genetic marker for diffentiating mycobacteria |
| 08/06/2008 | EP1468284B1 Method for measuring intracellular atp and/or gene expression |
| 08/06/2008 | EP1466015B1 Bioconjugate-nanoparticle probes |
| 08/06/2008 | EP1451348A4 Methods, reagents, kits and apparatus for protein function analysis |
| 08/06/2008 | EP1449920B1 Trangenic mice used as model for human pathologies originating from stem cells |
| 08/06/2008 | EP1444351B1 Genes encoding for carbon metabolism and energy-producing proteins |
| 08/06/2008 | EP1428890B1 Method of judging mismatch between single-stranded nucleic acid molecules |
| 08/06/2008 | EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 08/06/2008 | EP1385996B1 Charge tag and separation of nucleic acid molecules |
| 08/06/2008 | EP1379670B1 Activated dual specificity lymphocytes and their methods of use |
| 08/06/2008 | EP1377671B1 Oncolytic adenoviral vectors |
| 08/06/2008 | EP1366059B1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/06/2008 | EP1365643B1 Microinjection assembly and methods for microinjecting and reimplanting avian eggs |
| 08/06/2008 | EP1326879B1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 08/06/2008 | EP1313850B1 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 08/06/2008 | EP1283261B1 Method of screening drug acting on cell wall |
| 08/06/2008 | EP1257819B1 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1214410B1 Chimaeric plant viruses with mucin peptides |
| 08/06/2008 | EP1212449B1 Method for amplifying signal-flanking sequences from unknown genomic dna |
| 08/06/2008 | EP1204739B1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 08/06/2008 | EP1203006B1 Conditional-selex |
| 08/06/2008 | EP1192277B1 Diagnosis of restenosis |
| 08/06/2008 | EP1157042B1 Production of tetravalent antibodies |
| 08/06/2008 | EP1147133B1 Peptides consisting of two PTH functional domains fused by a linker molecule, and derivatives thereof |
| 08/06/2008 | EP1127168B1 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/06/2008 | EP1108034B1 Attenuated salmonella spi2 mutants as antigen carriers |
| 08/06/2008 | EP1078245B1 Instrument for monitoring polymerase chain reaction of dna |
| 08/06/2008 | EP1042467B1 Non-identical genes and their application in improved molecular adjuvants |
| 08/06/2008 | EP1023459B1 Determination of cyclin-dependent kinase inhibitor p27 levels as a prognostic factor in cancer patients |
| 08/06/2008 | EP1023447B1 Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 08/06/2008 | EP0941241B1 Bordetella strain expressing the fha hybrid, |
| 08/06/2008 | EP0938548B1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
| 08/06/2008 | EP0928339B1 Mammalian artificial chromosomes |
| 08/06/2008 | EP0870047B1 Episomal vector and uses thereof |
| 08/06/2008 | EP0832109B1 Fibroblast growth factor homologous factor-2 and methods of use |
| 08/06/2008 | EP0722336B1 Recombinant coffee bean alpha-galactosidase |
| 08/06/2008 | EP0666911B9 Multidrug resistance gene |
| 08/06/2008 | CN101238371A Method of manufacturing probe-immobilized carrier |
| 08/06/2008 | CN101238218A Transduction of primary cells |
| 08/06/2008 | CN101238217A Herbicide tolerant cotton plants and methods for identifying same |
| 08/06/2008 | CN101238216A Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 08/06/2008 | CN101238215A Methods and compositions for designing nucleic acid molecules for polypeptide expression in plants using plant virus codon-bias |
| 08/06/2008 | CN101238214A Treatment of disease using an improved regulated expression system |
| 08/06/2008 | CN101238213A Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (TINA) and process for the preparation of tina |
| 08/06/2008 | CN101238212A Methods for carrying out the selective evolution of proteinsin vivo |
| 08/06/2008 | CN101238209A 登革血清型2减毒株 Save dengue serotype 2 strain |